AP3004A - Process and intermediates for preparing integrase inhibitors - Google Patents
Process and intermediates for preparing integrase inhibitorsInfo
- Publication number
- AP3004A AP3004A AP2009004831A AP2009004831A AP3004A AP 3004 A AP3004 A AP 3004A AP 2009004831 A AP2009004831 A AP 2009004831A AP 2009004831 A AP2009004831 A AP 2009004831A AP 3004 A AP3004 A AP 3004A
- Authority
- AP
- ARIPO
- Prior art keywords
- intermediates
- integrase inhibitors
- preparing integrase
- preparing
- inhibitors
- Prior art date
Links
- 229940124524 integrase inhibitor Drugs 0.000 title 1
- 239000002850 integrase inhibitor Substances 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/68—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
- C07C227/10—Formation of amino groups in compounds containing carboxyl groups with simultaneously increasing the number of carbon atoms in the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
- C07C41/28—Preparation of ethers by reactions not forming ether-oxygen bonds from acetals, e.g. by dealcoholysis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C41/00—Preparation of ethers; Preparation of compounds having groups, groups or groups
- C07C41/01—Preparation of ethers
- C07C41/18—Preparation of ethers by reactions not forming ether-oxygen bonds
- C07C41/30—Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/18—Preparation of carboxylic acid esters by conversion of a group containing nitrogen into an ester group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/02—Lithium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84402006P | 2006-09-12 | 2006-09-12 | |
US90536507P | 2007-03-07 | 2007-03-07 | |
PCT/US2007/078157 WO2008033836A2 (en) | 2006-09-12 | 2007-09-11 | Process and intermediates for preparing integrase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2009004831A0 AP2009004831A0 (en) | 2009-04-30 |
AP3004A true AP3004A (en) | 2014-10-31 |
Family
ID=39092311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2009004831A AP3004A (en) | 2006-09-12 | 2007-09-11 | Process and intermediates for preparing integrase inhibitors |
Country Status (23)
Country | Link |
---|---|
US (3) | US7825252B2 (xx) |
EP (2) | EP2644587A3 (xx) |
JP (2) | JP5221544B2 (xx) |
KR (2) | KR101565169B1 (xx) |
CN (4) | CN105315154A (xx) |
AP (1) | AP3004A (xx) |
AR (1) | AR063710A1 (xx) |
AU (1) | AU2007296555B2 (xx) |
BR (1) | BRPI0716752A2 (xx) |
CA (1) | CA2661943C (xx) |
EA (1) | EA022099B1 (xx) |
ES (1) | ES2536923T3 (xx) |
HK (3) | HK1130466A1 (xx) |
HR (1) | HRP20090213B1 (xx) |
IL (2) | IL197527A (xx) |
MX (1) | MX2009002689A (xx) |
NO (1) | NO342907B1 (xx) |
NZ (1) | NZ575542A (xx) |
PT (1) | PT2069280E (xx) |
SG (2) | SG10201501782UA (xx) |
TW (1) | TWI411602B (xx) |
WO (1) | WO2008033836A2 (xx) |
ZA (1) | ZA200901576B (xx) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2470365C (en) * | 2002-11-20 | 2011-05-17 | Japan Tobacco Inc. | 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
EP2308490A1 (en) * | 2005-12-30 | 2011-04-13 | Gilead Sciences, Inc. | Methods for improving the pharmacokinetics of hiv integrase inhibitors |
ES2531190T3 (es) * | 2006-03-06 | 2015-03-11 | Japan Tobacco Inc | Método para producir un compuesto de 4-oxoquinolina |
CN101437801B (zh) | 2006-03-06 | 2013-02-06 | 日本烟草产业株式会社 | 制备4-氧代喹啉化合物的方法 |
TWI411602B (zh) | 2006-09-12 | 2013-10-11 | Gilead Sciences Inc | 製造整合酶抑制劑的方法及彼所用的中間物 |
JP5547066B2 (ja) * | 2007-06-29 | 2014-07-09 | ギリアード サイエンシーズ, インコーポレイテッド | 治療用組成物およびその使用 |
WO2009006203A1 (en) * | 2007-06-29 | 2009-01-08 | Gilead Sciences, Inc. | Therapeutic compositions and the use thereof |
AR068403A1 (es) * | 2007-09-11 | 2009-11-18 | Gilead Sciences Inc | Proceso e intermediarios para la preparacion de inhibidores de integrasa |
CA3131037A1 (en) | 2011-11-30 | 2013-06-06 | Emory University | Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections |
CN102603499A (zh) * | 2012-03-01 | 2012-07-25 | 南京药石药物研发有限公司 | 1-溴-4-氟-5-异丙基-2-甲氧基苯的合成方法 |
CN102746143A (zh) * | 2012-07-24 | 2012-10-24 | 上海灏翔生物科技有限公司 | L-薄荷羧酸的一种高立体选择性合成方法 |
ES2608860T3 (es) * | 2012-08-03 | 2017-04-17 | Gilead Sciences, Inc. | Proceso e intermedios para preparar inhibidores de la integrasa |
CZ304984B6 (cs) | 2012-10-12 | 2015-03-11 | Zentiva, K.S. | Zlepšený způsob výroby a nové intermediáty syntézy elvitegraviru |
CZ304983B6 (cs) * | 2012-10-12 | 2015-03-11 | Zentiva, K.S. | Způsob výroby a nové intermediáty syntézy elvitegraviru |
ES2926068T3 (es) | 2012-12-21 | 2022-10-21 | Gilead Sciences Inc | Compuestos de carbamoilpiridona policíclicos y su uso farmacéutico |
CZ307255B6 (cs) * | 2013-07-11 | 2018-05-02 | Zentiva, K.S. | Nový způsob přípravy elvitegraviru |
PT3252058T (pt) | 2013-07-12 | 2021-03-09 | Gilead Sciences Inc | Compostos policíclicos-carbamoílpiridona e seu uso para o tratamento de infecções por hiv |
NO2865735T3 (xx) | 2013-07-12 | 2018-07-21 | ||
TW201613936A (en) | 2014-06-20 | 2016-04-16 | Gilead Sciences Inc | Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide |
NO2717902T3 (xx) | 2014-06-20 | 2018-06-23 | ||
TWI677489B (zh) | 2014-06-20 | 2019-11-21 | 美商基利科學股份有限公司 | 多環型胺甲醯基吡啶酮化合物之合成 |
TWI738321B (zh) | 2014-12-23 | 2021-09-01 | 美商基利科學股份有限公司 | 多環胺甲醯基吡啶酮化合物及其醫藥用途 |
ES2837383T3 (es) | 2015-04-02 | 2021-06-30 | Gilead Sciences Inc | Compuestos de carbamoilpiridonas policíclicos y su utilización farmacéutica |
CN112661698A (zh) * | 2021-01-14 | 2021-04-16 | 浙江海森药业股份有限公司 | 一种艾维雷韦的制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1564210A1 (en) * | 2002-11-20 | 2005-08-17 | Japan Tobacco Inc. | 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
WO2005113509A1 (en) * | 2004-05-20 | 2005-12-01 | Japan Tobacco Inc. | Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
WO2005112930A1 (en) * | 2004-05-21 | 2005-12-01 | Japan Tobacco Inc. | Combinations comprising a 4-isoquinolone derivative and anti-hiv agents |
WO2007102512A1 (ja) * | 2006-03-06 | 2007-09-13 | Japan Tobacco Inc. | 4-オキソキノリン化合物の製造方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US93482A (en) * | 1869-08-10 | Improved roofing-composition | ||
US36684A (en) * | 1862-10-14 | Improvement in tailors press-board holders | ||
US93467A (en) * | 1869-08-10 | Improved machine for bending car-hooks | ||
US999366A (en) * | 1910-09-30 | 1911-08-01 | John M Gilmore | Device for the manufacture of dental crowns. |
DE3501247A1 (de) * | 1985-01-16 | 1986-07-17 | Bayer Ag, 5090 Leverkusen | Aminoacrylsaeure-derivate |
AU2905702A (en) | 2000-12-14 | 2002-06-24 | Procter & Gamble | Cyclization process step in the making of quinolones and naphthyridines |
TW200300349A (en) * | 2001-11-19 | 2003-06-01 | Sankyo Co | A 4-oxoqinoline derivative |
JPWO2003101916A1 (ja) | 2002-05-31 | 2005-09-29 | 萬有製薬株式会社 | ハロゲン−金属交換反応による置換基の導入法 |
US6803469B2 (en) * | 2002-08-05 | 2004-10-12 | The Procter & Gamble Company | Process for preparing quinolone antibiotic intermediates |
TW200409759A (en) | 2002-09-25 | 2004-06-16 | Wyeth Corp | Substituted 4-(indazol-3-yl)phenols |
CN100375742C (zh) * | 2002-11-20 | 2008-03-19 | 日本烟草产业株式会社 | 4-氧代喹啉化合物及其用途 |
EP1582523A1 (en) | 2004-04-02 | 2005-10-05 | Ludwig-Maximilians-Universität München | Method of preparing organomagnesium compounds |
EP1582524B1 (en) | 2004-04-02 | 2008-08-13 | Ludwig Maximilians Universität | Method of preparing organomagnesium compounds |
MY134672A (en) | 2004-05-20 | 2007-12-31 | Japan Tobacco Inc | Stable crystal of 4-oxoquinoline compound |
WO2007063869A1 (ja) | 2005-11-30 | 2007-06-07 | Japan Tobacco Inc. | 高純度キノロン化合物の製造方法 |
US20090233964A1 (en) * | 2005-12-30 | 2009-09-17 | Gilead Sciences, Inc. | Methods for improving the pharmacokinetics of hiv integrase inhibitors |
CN101437801B (zh) | 2006-03-06 | 2013-02-06 | 日本烟草产业株式会社 | 制备4-氧代喹啉化合物的方法 |
TW200811153A (en) * | 2006-06-23 | 2008-03-01 | Japan Tobacco Inc | 6-(heterocyclyl-substituted benzyl)-4-oxoquinoline compound and use thereof as HIV integrase inhibitor |
TWI411602B (zh) | 2006-09-12 | 2013-10-11 | Gilead Sciences Inc | 製造整合酶抑制劑的方法及彼所用的中間物 |
JP5547066B2 (ja) | 2007-06-29 | 2014-07-09 | ギリアード サイエンシーズ, インコーポレイテッド | 治療用組成物およびその使用 |
WO2009006203A1 (en) | 2007-06-29 | 2009-01-08 | Gilead Sciences, Inc. | Therapeutic compositions and the use thereof |
AR068403A1 (es) | 2007-09-11 | 2009-11-18 | Gilead Sciences Inc | Proceso e intermediarios para la preparacion de inhibidores de integrasa |
-
2007
- 2007-09-11 TW TW096133911A patent/TWI411602B/zh not_active IP Right Cessation
- 2007-09-11 KR KR1020097007377A patent/KR101565169B1/ko active IP Right Grant
- 2007-09-11 BR BRPI0716752-0A2A patent/BRPI0716752A2/pt not_active IP Right Cessation
- 2007-09-11 AR ARP070104017A patent/AR063710A1/es unknown
- 2007-09-11 CA CA2661943A patent/CA2661943C/en not_active Expired - Fee Related
- 2007-09-11 WO PCT/US2007/078157 patent/WO2008033836A2/en active Application Filing
- 2007-09-11 NZ NZ575542A patent/NZ575542A/en not_active IP Right Cessation
- 2007-09-11 JP JP2009528433A patent/JP5221544B2/ja not_active Expired - Fee Related
- 2007-09-11 MX MX2009002689A patent/MX2009002689A/es active IP Right Grant
- 2007-09-11 CN CN201510922236.5A patent/CN105315154A/zh active Pending
- 2007-09-11 US US11/853,606 patent/US7825252B2/en active Active
- 2007-09-11 CN CN201510922511.3A patent/CN105503721A/zh active Pending
- 2007-09-11 AU AU2007296555A patent/AU2007296555B2/en not_active Ceased
- 2007-09-11 KR KR1020127031758A patent/KR101555089B1/ko active IP Right Grant
- 2007-09-11 EP EP13174174.6A patent/EP2644587A3/en not_active Withdrawn
- 2007-09-11 CN CN201210224990.8A patent/CN102766098B/zh not_active Expired - Fee Related
- 2007-09-11 AP AP2009004831A patent/AP3004A/xx active
- 2007-09-11 PT PT78422425T patent/PT2069280E/pt unknown
- 2007-09-11 SG SG10201501782UA patent/SG10201501782UA/en unknown
- 2007-09-11 CN CN2007800339076A patent/CN101516819B/zh not_active Expired - Fee Related
- 2007-09-11 SG SG2011064623A patent/SG174787A1/en unknown
- 2007-09-11 ES ES07842242.5T patent/ES2536923T3/es active Active
- 2007-09-11 EP EP07842242.5A patent/EP2069280B1/en active Active
- 2007-09-11 EA EA200900441A patent/EA022099B1/ru not_active IP Right Cessation
-
2009
- 2009-03-05 ZA ZA2009/01576A patent/ZA200901576B/en unknown
- 2009-03-11 IL IL197527A patent/IL197527A/en active IP Right Grant
- 2009-04-07 NO NO20091415A patent/NO342907B1/no not_active IP Right Cessation
- 2009-04-09 HR HRP20090213AA patent/HRP20090213B1/hr not_active IP Right Cessation
- 2009-10-12 HK HK09109398.0A patent/HK1130466A1/xx unknown
-
2010
- 2010-09-28 US US12/892,682 patent/US8324244B2/en active Active
-
2012
- 2012-06-12 IL IL220311A patent/IL220311A/en active IP Right Grant
- 2012-09-14 US US13/619,297 patent/US8796459B2/en active Active
- 2012-10-18 JP JP2012230583A patent/JP2013047248A/ja not_active Withdrawn
-
2016
- 2016-08-10 HK HK16109486.4A patent/HK1221454A1/zh unknown
- 2016-10-08 HK HK16111670.6A patent/HK1223370A1/zh unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1564210A1 (en) * | 2002-11-20 | 2005-08-17 | Japan Tobacco Inc. | 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors |
WO2005113509A1 (en) * | 2004-05-20 | 2005-12-01 | Japan Tobacco Inc. | Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
WO2005112930A1 (en) * | 2004-05-21 | 2005-12-01 | Japan Tobacco Inc. | Combinations comprising a 4-isoquinolone derivative and anti-hiv agents |
WO2007102512A1 (ja) * | 2006-03-06 | 2007-09-13 | Japan Tobacco Inc. | 4-オキソキノリン化合物の製造方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1223370A1 (zh) | 製備整合酶抑制劑的方法和中間體 | |
AP2785A (en) | Process and intermediates for preparing integrase inhibitors | |
EP2376453A4 (en) | PROCESSES AND INTERMEDIATE PRODUCTS FOR CARBAMOYLPYRIDONE AS HIV INTEGRASE INHIBITORS | |
IL250068A0 (en) | Method and intermediates for preparing pharmaceutical substances | |
IL198117A0 (en) | Process for preparing indol-5-oxy-quinazoline derivatives and intermediates | |
EP2024341A4 (en) | NEW PROCEDURES FOR STATINE AND THEIR PHARMACEUTICALLY UNINTENTIONAL SALTS | |
EP2000529A4 (en) | CULTURE APPARATUS | |
PL2280803T5 (pl) | Monolityczne urządzenie magnetyczne oraz sposób wytwarzania monolitycznego urządzenia magnetycznego | |
IL181607A0 (en) | Novel process for preparing montelukast and salts thereof | |
ZA200903889B (en) | Process for the synthesis of moxifloxacin hydrochloride | |
IL202228A0 (en) | Process for preparing bepotastine and intermediates used therein | |
ZA200901676B (en) | Process and apparatus for hot-forging synthetic ceramic | |
IL185627A (en) | A process for making alkyl-anilides and their intermediates | |
TWI371443B (en) | Process and apparatus for preparing alkyl methacrylates | |
EP2244561A4 (en) | APPARATUS FOR CONCHYLICULTURE | |
IL180860A0 (en) | Process for preparing montelukast and precursors thereof | |
SI2044099T1 (sl) | Postopek priprave S-fluorometil-6,9-difluoro-11-hidroksi-16-metil-17-propioniloksi-3-okso -androsta-1,4-dien-17-karbotioata in vmesnih spojin | |
ZA201000397B (en) | Process for preparing oxazolidine-and oxazolidinone-aminodiols and related intermediates | |
GB0625899D0 (en) | Apparatus for the cultivation of shellfish | |
EP2142561A4 (en) | PROCESS FOR PREPARING AROMATASE INHIBITORS | |
IL195059A0 (en) | Process for preparing duloxetine and intermediates thereof | |
IL193529A0 (en) | Process for preparing l-nucleic acid derivatives and intermediates thereof | |
IL199785A0 (en) | Process and intermediates for preparing arzoxifene | |
IL193470A0 (en) | Process for preparing of 2-alkyl-3-aryl-prop-2- ene-1-ols | |
EP2057113A4 (en) | METHOD FOR PRODUCING PSEUDONOREPHEDRINE |